Balchem slides after Q1 results as investors sell-the-news despite record quarter
Balchem shares fell about 5.9% on April 30, 2026 after the company released Q1 FY2026 results and investors sold the news despite record quarterly results. Balchem reported net sales of $270.7 million and GAAP EPS of $1.25 for the quarter ended March 31, 2026.
1) What’s driving BCPC lower today
Balchem (BCPC) is trading lower on Thursday, April 30, 2026, after the company published its first-quarter fiscal 2026 earnings release and investors reacted by taking profits. The move has the feel of a sell-the-news reaction: the company posted record first-quarter net sales, adjusted EBITDA, and net earnings, but the stock is down as the market digests the details ahead of the scheduled conference call later this morning. �citeturn1view0
2) The headline numbers
For the fiscal first quarter ended March 31, 2026, Balchem reported net sales of $270.7 million, GAAP net earnings of $40.3 million, and GAAP EPS of $1.25. The company also reported adjusted EPS of $1.33, adjusted EBITDA of $74.3 million, and free cash flow of $33.8 million, with year-over-year growth highlighted across its reporting segments. �citeturn1view0
3) What investors will watch next
With the results now out, the next catalyst is management’s Q1 earnings call scheduled for 11:00 a.m. ET, where investors will listen for updates on pricing, input costs, and the durability of demand across Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Any incremental commentary on the trajectory for fiscal 2026 could determine whether today’s pullback stabilizes or extends. �citeturn1view0